- Record: found
- Abstract: not found
- Article: not found
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
Willem D F Venter ,
Michelle Moorhouse ,
Simiso Sokhela ,
Celicia Serenata ,
Godspower Akpomiemie ,
Ambar Qavi ,
Nonkululeko Mashabane ,
Natasha Arulappan ,
Joel W Sim ,
Phumla Z Sinxadi ,
Lubbe Wiesner ,
Ellisha Maharaj ,
Carole Wallis ,
Tom Boyles ,
David Ripin ,
Sarah Stacey ,
Gila Chitauri ,
Andrew Hill
June 2019
June 2019
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.